Research - 7investing 7investing
Stock Tips Mobile Menu Dropdown Icon

Stock Market Research

Better investing begins with better research.

7investing Stock Market Research

Being your own investor doesn’t mean you have to go it alone. Improve your investing insights with the stock market research of the 7investing lead advisors. 

Our team dives deeper, going beyond the tickers and trends to provide you with the credible, actionable information you need to make the right moves and achieve your stock market investing goals. Read on to stay up to date with the latest 7investing research articles, podcasts, videos, and updates on your favorite companies. 


An Upcoming Change for 7investing (Part Deux):

Jul 17, 2024

We have some big news to announce!

Recent Research


NIKE: Short-Term Pain, Long-Term Gain?

Jul 16, 2024

Is the global athletic wear king current an excellent investment opportunity?


Cassava Sciences: Is The Fraud Investigation Just Smoke…or an Actual…

Jul 1, 2024

This micro-cap biotech company is working on an innovative cure to Alzheimer's Disease but is surrounded by controversy. Is it worth the risk for investors?


A Tale of Two Cybersecurity Leaders

Jun 10, 2024


Illumina Officially Ends Its Quest for the Holy GRAIL

Jun 7, 2024

After feeling the heat from investors, customers, and regulators, Illumina has finally agreed to divest GRAIL.


50 Quotes from Legendary Value Investor Joel Tillinghast

May 24, 2024

Guest writer John Rotonti shares several of the best quotes from legendary value investor Joel Tillinghast.


dLocal’s Margins Compress; Announces Stock Buyback

May 23, 2024

The international payment processor had a mixed quarter. See our key takeaways for investors.


Introducing 7investing’s Stockpicking Competition!

Mar 4, 2024

Enter to win a $1,000 Amazon gift card and a free year of 7investing.


Is Tech Hiring Picking Back Up?

Feb 15, 2024

Encouraging data shows that (some) tech companies are looking for new engineering talent.


AI is Bringing Synthetic Biology Back to Life

Feb 6, 2024

New AI tools could supercharge the emerging field of generative biology. The therapeutics segment might be a natural fit.


Investing in the Cloud: Mission-Critical, Land-and-Expand, and Sustainable Growth

Jan 22, 2024

Guest contributor Anand Khatri from StocksCurrent describes how investors should approach the cloud computing industry.


2024 NFL Mock Draft 1.0

Jan 21, 2024

7investing CEO Simon Erickson shares his mock draft outlook of what NFL fans should expect this April.


Why Seres Therapeutics is My Best Buy in January

Jan 17, 2024

The market's first microbiome company is getting a good reception to its first commercially-approved drug.


ZoomInfo: Time for a Turnaround?

Jan 11, 2024

The sales platform looks primed for a turnaround.